Press release
Chronic Pain Market Size is Set for Rapid Growth as Innovative Treatments and Rising Awareness Drive Demand by 2034
Chronic Pain Market
[Nevada, United States] - DelveInsight's "Chronic Pain Market Insights, Epidemiology, and Market Forecast 2034." report offers a detailed examination of Chronic Pain, covering historical and predicted epidemiology, market trends, and treatment scenarios in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
To Know in detail about the Chronic Pain Market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; https://www.delveinsight.com/sample-request/chronic-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Key Findings from the Chronic Pain Market Report:
• The Chronic Pain market size is poised for significant growth, with an anticipated Compound Annual Growth Rate (CAGR) during the study period (2020-2034).
• In October, 2024: Novartis Pharmaceuticals announced that their study was designed to demonstrate the safety and efficacy of two dose concentrations of SAF312 eye drops (5 mg/mL and 15 mg/mL) in subjects with CICP persisting at least for 4 months after refractive or cataract surgery and chronicity confirmed during the observational period. The study also determined the optimal dose to carry forward for further development.
• In September, 2024: Ethos Research & Development announced that the goal of their study is to use pain-specific urine biomarkers to evaluate how daily nutritional supplementation with biomarker guided formulas effect quality of life and urinary biomarker scores in chronic pain patients. Assessing the effect of biomarker guided supplementation on pain specific biomarkers through changes in urinary biomarker scores may solidify the necessity for identifying deficiencies to create an individualized treatment plan for pain patients.
• In August, 2024: Eli Lilly and Company announced that the main purpose of their study is to assess whether LY3857210 is safe and efficacious in relieving chronic low back pain (CLBP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.
• In July, 2024: Sustained Therapeutics Inc. announced that a multi-center, phase 2, randomized, single-blind, three-arm, active-controlled study is comparing repeat doses, every 28 days, of standard of care (SOC) plus ST-01 against SOC plus 1% lidocaine HCL in men experiencing chronic scrotal content pain (CSCP). The main purpose of this study is to determine if repeat injections of ST-01 are safe and effective in reducing pain.
• Key Chronic Pain Companies are as follows: AbbVie, Paradigm Biopharmaceuticals Ltd., Noven Pharmaceuticals, Inc., Pfizer, Anika Therapeutics, Inc., Biogen, Tonix Pharmaceuticals, Inc., Taiwan Liposome Company, Centrexion Therapeutics, Braeburn Pharmaceuticals, Regeneron, Teva Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Vertanical Gmbh
• Key Chronic Pain Therapies are as follow: JOYCLU (diclofenac etalhyaluronate sodium), ZILRETTA, ZILOSUL, TNX-102 SL, ST-0, Adezunap (AP707), JNS020QD, Hydrocodone Bitartrate, Oxycodone/naloxone, Hydrocodone, Oxymorphone Extended Release, DuragesicÂ, Duloxetine hydrochloride, buprenorphine, Oxymorphone ER, HCl ER
• Launching multiple stage Chronic Pain pipeline products is expected to revolutionize market dynamics, further propelling market growth.
Dive into our detailed Chronic Pain market research report to uncover actionable insights, industry forecasts, and competitive analysis @ https://www.delveinsight.com/report-store/chronic-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Chronic Pain Overview:
Chronic pain is usually not diagnosed until the patient has regularly been in pain for three to six months. Diagnosis often involves a series of tests and procedures, as well as a review of symptoms and medical history. The tests performed by the doctor depending on where the pain is located and what is causing it, in addition to other symptoms. Different tests may include are blood tests, imaging, and nerve testing.
Chronic Pain Epidemiology Segmentation:
The Chronic Pain market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Chronic Pain Total Prevalent Cases
• Chronic Pain Severity-specific Cases
• Chronic Pain Total Diagnosed Cases
• Chronic Pain Age-Specific Cases
For more information about Chronic Pain companies working in the treatment market, visit Chronic Pain Clinical Trials
Chronic Pain Market Insights
The global chronic pain market was valued at over USD 85 billion in 2023, and it is expected to grow at a compound annual growth rate (CAGR) of around 4-5% over the next five years. This market expansion is driven by the increasing number of patients with chronic pain conditions, the growing elderly population, and the development of novel therapies that offer improved efficacy and fewer side effects compared to traditional pain management options.
Chronic Pain Drugs Uptake
• Lyrica continues to dominate the chronic pain market. Despite facing generic competition since its patent expiry, it remains a key player due to its efficacy in treating conditions like fibromyalgia, diabetic neuropathy, and spinal cord injuries.
• Gabapentin remains a widely used medication for chronic neuropathic pain, particularly in patients who do not tolerate opioids well. Its generic availability has increased its uptake in both developed and developing markets.
• NSAIDs such as ibuprofen and naproxen are commonly prescribed for musculoskeletal pain, including conditions like osteoarthritis and rheumatoid arthritis. Although effective, their long-term use is limited due to concerns about gastrointestinal and cardiovascular side effects.
• Topical treatments, including lidocaine and capsaicin patches, are gaining popularity due to their localized action and minimal systemic side effects. These options are particularly useful for patients who prefer non-systemic treatments or those at risk of opioid dependence.
Dive into our comprehensive market research report to discover in-depth insights, emerging trends, and strategic opportunities @ https://www.delveinsight.com/sample-request/chronic-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Chronic Pain Therapies and Key Companies:
• JOYCLU (diclofenac etalhyaluronate sodium): Seikagaku Corporation
• ZILRETTA: Pacira BioSciences
• ZILOSUL: Paradigm Biopharmaceuticals.
• TNX-102 SL: Tonix Pharmaceuticals
• ST-01: Sustained Therapeutics Inc.
• Adezunap (AP707): Apurano Pharmaceuticals GmbH
• JNS020QD: Janssen Pharmaceutical K.K.
• Hydrocodone Bitartrate: Zogenix, Inc.
• Oxycodone/naloxone: Mundipharma Korea Ltd
• Hydrocodone: NEMA Research, Inc.
• Oxymorphone Extended Release: Endo Pharmaceuticals
• DuragesicÂ: Johnson & Johnson
• Duloxetine hydrochloride: Eli Lilly and Company
• buprenorphine: Braeburn Pharmaceuticals
• Oxymorphone ER: MedVadis Research Corporation
• HCl ER: Bausch Health Americas, Inc.
Chronic Pain Epidemiology:
The epidemiology section provides insights into historical, current, and forecasted trends in the seven major countries (7MM) from 2020 to 2034. It explores various studies and opinions to recognize the causes of current and forecasted trends. The segmentation includes total prevalence, severity-based prevalence, gender-specific prevalence, and diagnosed cases of episodic and chronic Chronic Pain.
Seize Market Opportunities with Our Expert Analysis! Our report delivers valuable insights into market dynamics, key players, and emerging trends @ https://www.delveinsight.com/sample-request/chronic-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Chronic Pain Market Drivers:
• Rising Prevalence of Chronic Pain Conditions
• Growing Geriatric Population
• Advances in Non-Opioid Therapies
• Technological Innovations in Pain Management
Chronic Pain Market Barriers:
• Opioid Crisis and Regulatory Challenges
• High Cost of Novel Therapies
• Lack of Long-Term Data on New Therapies
• Adverse Effects of Pain Medications
Stay Ahead in a Competitive Landscape with Our Exhaustive Market Research Report-Dive Into Detailed Analysis, Key Trends, and Future Projections @ https://www.delveinsight.com/sample-request/chronic-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Scope of the Chronic Pain Market Report:
• Study Period: 2020-2034
• Coverage: 7MM (The United States, EU5, and Japan)
• Key Chronic Pain Companies: AbbVie, Paradigm Biopharmaceuticals Ltd., Noven Pharmaceuticals, Inc., Pfizer, Anika Therapeutics, Inc., Biogen, Tonix Pharmaceuticals, Inc., Taiwan Liposome Company, Centrexion Therapeutics, Braeburn Pharmaceuticals, Regeneron, Teva Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Vertanical Gmbh
• Key Chronic Pain Therapies: JOYCLU (diclofenac etalhyaluronate sodium), ZILRETTA, ZILOSUL, TNX-102 SL, ST-0, Adezunap (AP707), JNS020QD, Hydrocodone Bitartrate, Oxycodone/naloxone, Hydrocodone, Oxymorphone Extended Release, DuragesicÂ, Duloxetine hydrochloride, buprenorphine, Oxymorphone ER, HCl ER
• Chronic Pain Therapeutic Assessment: Current marketed and emerging therapies
• Chronic Pain Market Dynamics: Chronic Pain Market drivers and Chronic Pain barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Chronic Pain Unmet Needs: Insights into unmet needs, KOL's views, Analyst's views, Market Access, and Reimbursement.
To access the full report and gain a deeper understanding of Chronic Pain market outlook, drug uptake, treatment scenario, and epidemiology trends, https://www.delveinsight.com/sample-request/chronic-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Table of Content:
1 Key Insights
2 Report Introduction
3 Chronic Pain Market Overview at a Glance
4 Executive Summary of Chronic Pain
5 Key events
6 Disease Background and Overview
7 Epidemiology and Patient Population
8 Patient Journey
9 Marketed Products
10 Emerging Therapies
List to be continued in full report
11 Chronic Pain: The Seven Major Markets Analysis
12 SWOT Analysis
13 Unmet Needs
14 KOL Views
15 Market Access and Reimbursement
16 Appendix
17 DelveInsight Capabilities
18 Disclaimer
19 About DelveInsight
About DelveInsight:
DelveInsight is a leading market research firm providing insightful solutions and services to pharmaceutical and life sciences companies. With a commitment to delivering accurate and comprehensive reports, DelveInsight empowers businesses to make informed decisions and navigate the complexities of the healthcare industry.
Contact Information:
Company Name: DelveInsight Business Research LLP
Contact Person: Ram Kapoor
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Pain Market Size is Set for Rapid Growth as Innovative Treatments and Rising Awareness Drive Demand by 2034 here
News-ID: 3698976 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Pain
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description
Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical…
